1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice
- PMID: 32554245
- DOI: 10.1016/j.biopha.2020.110348
1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice
Abstract
Non-alcoholic fatty liver disease (NAFLD) is currently the most frequently occurring liver disorder in the world. However, a specific drug for the treatment of patients with NAFLD is not available. Therefore, the discovery of novel compounds for the treatment of NAFLD and elucidation of the underlying mechanisms of therapeutic drugs that can be used to treat this disease are urgently needed. 1,2,3,4,6 penta-O-galloyl-β-d-glucose (PGG) is known to exert anti-inflammatory, antidiabetic, and hepatoprotective effects. However, little is known about the therapeutic potential of PGG in NAFLD. In this study, we investigated the effects of PGG on a high-fat diet (HFD)-induced mouse model of NAFLD. PGG was co-administered along with an HFD to C57BL/6 mice. After eight weeks of treatment, serum biochemistry, liver steatosis, and lipid metabolism-related genes were examined. The results showed that PGG treatment significantly reduced HFD-induced gain in body weight, liver steatosis, and leukocyte infiltration in a dose-dependent manner. Furthermore, PGG treatment markedly reduced serum triglyceride and glucose levels in HFD mice. Moreover, alterations in the mRNA expression of genes involved in lipid metabolism, including Hmgcr, Acc1, Abca1, Mttp, and Cd36, observed in the livers of HFD-treated mice were significantly reversed by PGG treatment. PGG significantly reduced HFD-induced protein expression of CD36, which is associated with fatty acid uptake, insulin resistance, hyperinsulinemia, and increased hepatic steatosis, in the liver of HFD mice. These results suggest that PGG inhibits HFD-induced hepatic steatosis and reverses HFD-induced alterations of gene expression in lipid metabolism. PGG has been shown to be well tolerated; therefore, it has potential uses in NAFLD treatment.
Keywords: Cd36; Hepatic lipid metabolism; High-Fat diet; NAFLD; PGG.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Similar articles
-
Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.J Ethnopharmacol. 2020 Jun 12;255:112556. doi: 10.1016/j.jep.2020.112556. Epub 2020 Jan 9. J Ethnopharmacol. 2020. PMID: 31926984
-
The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).Mol Med. 2020 Jun 5;26(1):54. doi: 10.1186/s10020-020-00164-4. Mol Med. 2020. PMID: 32503411 Free PMC article.
-
The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.Toxicology. 2019 Mar 15;416:1-14. doi: 10.1016/j.tox.2019.01.017. Epub 2019 Jan 31. Toxicology. 2019. PMID: 30711707
-
Biological and biomedical functions of Penta-O-galloyl-D-glucose and its derivatives.J Nat Med. 2014 Jul;68(3):465-72. doi: 10.1007/s11418-014-0823-2. Epub 2014 Feb 15. J Nat Med. 2014. PMID: 24532420 Review.
-
Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease.Nutrients. 2023 May 16;15(10):2323. doi: 10.3390/nu15102323. Nutrients. 2023. PMID: 37242206 Free PMC article. Review.
Cited by
-
Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice.Front Nutr. 2022 Aug 17;9:983450. doi: 10.3389/fnut.2022.983450. eCollection 2022. Front Nutr. 2022. PMID: 36071929 Free PMC article.
-
Tamoxifen induced hepatic steatosis in high-fat feeding rats through SIRT1-Foxo1 suppression and LXR-SREBP1c activation.Toxicol Res (Camb). 2022 Jul 22;11(4):673-682. doi: 10.1093/toxres/tfac043. eCollection 2022 Aug. Toxicol Res (Camb). 2022. PMID: 36051666 Free PMC article.
-
Investigation of the inhibition effect of 1,2,3,4,6-pentagalloyl-β-D-glucose on gastric cancer cells based on a network pharmacology approach and experimental validation.Front Oncol. 2022 Aug 3;12:934958. doi: 10.3389/fonc.2022.934958. eCollection 2022. Front Oncol. 2022. PMID: 35992839 Free PMC article.
-
Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.Free Neuropathol. 2021;2:2-33. doi: 10.17879/freeneuropathology-2021-3528. Epub 2021 Dec 13. Free Neuropathol. 2021. PMID: 34977908 Free PMC article.
-
Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications.Int J Mol Sci. 2021 Jun 6;22(11):6110. doi: 10.3390/ijms22116110. Int J Mol Sci. 2021. PMID: 34204038 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
